Magnification x2 of Fig 1B. حسب Huan W. Yang (19746645)

الموضوعات:

Magnification X2 of Fig 4A. حسب Huan W. Yang (19746645)

الموضوعات:

Log2 fold change (FC) of the overlaps of lipid metabolites between the study groups and those significant metabolites that appear exclusively in a single group (unique) represented... حسب Laia Bertran (3685147)

Coverage of plant species in each plot. حسب Xuemei Xiang (20756894)

الموضوعات:

Specifications and effects of heating devices. حسب Xuemei Xiang (20756894)

الموضوعات:

Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database. حسب Yu Zhang (12946)

الموضوعات:

Additional file 1 of Short-term oral zinc supplementation enhances Natural Killer cell functionality and decreases circulating Innate Lymphoid Cell counts and frequencies in health... حسب Lara Amling (20882028)

Path analysis diagram illustrating the associations between alexithymia, social support, anticipated stigma and patient satisfaction, with their respective correlation coefficients... حسب Keya Bibikar (22386306)

P values of Kruskal–Wallis test at 95% significance level. حسب Fahd Saeed Alakbari (10701871)

الموضوعات:

Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... حسب Felix Alexandre Schoeller (20988295)

الموضوعات:

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. حسب Hala Tamim El Jarkass (16625309)

الموضوعات:

Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. حسب Mucahit Gemici (21519313)

One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. حسب Mucahit Gemici (21519313)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات: